1. I.H.T. Guideline, Specifications: test procedures and acceptance criteria for new drug substances and new drug products: chemical substances, Q6A. Step, 4 (2000).
2. U.S.F.D. Administration, CFR - code of federal regulations title 21 PART 314 applications for FDA approval to market a new drug, 2016.
3. Dealing with the impact of ritonavir polymorphs on the late stages of bulk drug process development;Chemburkar;Org. Process Res. Dev.,2000
4. The improved compaction properties of mannitol after a moisture-induced polymorphic transition;Yoshinari;Int. J. Pharm.,2003
5. Polymorphic forms of piracetam;Pavlova;Pharmazie,1979